The Novartis Hasanuddin Clinical Research Initiative (NHCRI) is a joint clinical research program undertaken by Novartis and Indonesia’s Hasanuddin University. The disease areas and mission are in line with those of the Novartis Institute for Tropical Diseases (NITD).
The collaboration aims to create value by bringing together know-how, expertise, technologies and financial resources to serve the needs of tropical, rural populations exposed to certain neglected, tropical diseases. Current activities include diagnosis of TB and Dengue cases, epidemiological and operational research, TB molecular epidemiology research and development of Dengue diagnostic kits.
|Location||Indonesia, East Asia and Pacific|